Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma
Katherine E. Fero(UCLA Health), Stephen B. Williams(Cedars-Sinai Medical Center), Jacques Baillargeon(The University of Texas Medical Branch at Galveston), Patrick M. Lec(University of California, Los Angeles), Karim Chamie(University of California, Los Angeles), Giri Movva(The University of Texas Medical Branch at Galveston), Vidit Sharma(University of California, Los Angeles), Yong Shan(The University of Texas Medical Branch at Galveston), Aditya Srinivasan(The University of Texas Medical Branch at Galveston)
Cited by 8
Related Papers
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Epidemiology, Screening, and Prevention of Bladder Cancer
|European Urology Oncology|2022|361
Trends in Androgen Prescribing in the United States, 2001 to 2011
|JAMA Internal Medicine|2013|331
What Is the Significance of Variant Histology in Urothelial Carcinoma?
|European Urology Focus|2019|251